ACUMEN PHARMACEUTICALS INC (ABOS) Stock Cash Flow
NASDAQ:ABOS - Nasdaq - US00509G2093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -116.25M | -102.33M | -52.37M | -42.86M | -100.61M | |||
| Depreciation Amortization | 183.00K | 178.00K | 184.00K | 30.00K | 0.00 | |||
| Change In Working Capital | 8.36M | 11.65M | 3.87M | 3.99M | 300.00K | |||
| Interest Paid | 2.94M | 2.97M | 169.00K | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.24M | 4.28M | 5.26M | 3.69M | 82.34M | |||
| OPERATING CASH FLOW | -102.34M | -86.22M | -43.06M | -35.15M | -17.96M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -85.00K | -16.00K | -21.00K | -160.00K | -40.00K | |||
| Other Investing Activity | 86.00M | 48.04M | -171.65M | 39.35M | -104.08M | |||
| INVESTING CASH FLOW | 85.92M | 48.03M | -171.67M | 39.19M | -104.12M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -739.00K | 30.00M | N/A | N/A | |||
| Stock Issued/Repurchased | -49.00K | 7.90M | 122.23M | 3.91M | 200.47M | |||
| Other Financing Activity | 570.00K | -230.00K | -476.00K | N/A | N/A | |||
| FINANCING CASH FLOW | -218.00K | 6.93M | 151.75M | 3.91M | 200.47M | |||
| CHANGE IN CASH | -16.64M | -31.26M | -62.98M | 7.95M | 78.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -102.34M | -86.22M | -43.06M | -35.15M | -17.96M | |||
| Capital Expenditure | -85.00K | -16.00K | -21.00K | -160.00K | -40.00K | |||
| FREE CASH FLOW | -102.42M | -86.23M | -43.09M | -35.31M | -18.00M | |||
All data in USD